Latest News

January 17, 2025

The Winter 2025 advocacy blog Considering Clinical Trials is now available

January 16, 2025

Major breast cancer screening trial hits enrollment goal (features TMIST)

January 16, 2025

TMIST breast cancer screening trial reaches enrollment milestone, advancing precision screening techniques

January 15, 2025

Press Release: Large-scale TMIST breast cancer screening trial achieves enrollment goal, paving the way for data that provides a precision approach to screening

January 14, 2025

Cellular therapies and novel targeted agents will shape the future of acute lymphoblastic leukemia management (mentions E1910)

January 10, 2025

Adjuvant tamoxifen reduces 15-year risk of recurrence in ‘good risk’ DCIS without radiation therapy (mentions E5194)

January 8, 2025

WATCH: A recent FDA approval of blinatumomab was supported by data from the E1910 trial

January 8, 2025

Active monitoring is promising for women with low-risk ductal carcinoma in situ (features E5194)

January 6, 2025

Can we omit stem cell transplants in patients with mantle cell lymphoma with undetectable residual disease? (features EA4151)


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
42

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group